A new study in JCP found that higher BMI was significantly associated with remission in patients on #clozapine, supporting the idea of a “metabolic threshold” for antipsychotic efficacy. 🔗 Read more in our current issue: journals.lww.com/psychopharmaco…

Centanafadine, a potential first-in-class NDSRI, showed sustained symptom improvement and was well tolerated over 52 weeks in adults with #ADHD. No signs of abuse or withdrawal. A promising nonstimulant option. 🔗 Read more in our current issue: journals.lww.com/psychopharmaco…

We are pleased to announce an exciting opportunity for early-career researchers: JCP is now accepting applications for its inaugural Editorial Fellowship Program. This 2-year, paid fellowship offers hands-on experience in academic publishing and psychiatric research. Apply today!

Pathologic #laughter is rare and often treated with SSRIs. However, a new JCP case report describes it paradoxically triggered by #sertraline in a patient with depression and no neuro findings. A reminder to monitor for atypical SSRI effects. 🔗Read more: journals.lww.com/psychopharmaco…

A newly published comprehensive systematic review in JCP analyzes all FDA-approved psychiatric medications for sleep-wake disorders from 2008 to 2024. The review details mechanisms of action, indications, efficacy, dosing, and adverse effects. 🔗Read more: journals.lww.com/psychopharmaco…

The Journal of Clinical Psychopharmacology is building a presence on Bluesky, and we’d love for our X community to be part of it. Follow us on Bluesky for early updates, featured research, and insight into psychopharmacology trends. 📲 @ psychopharm.bsky.social

While #aripiprazole is generally well tolerated, a new review in the Journal of Clinical Psychopharmacology highlights rare cases of #rhabdomyolysis, even at standard or low doses. 🔗Read more in our current issue: journals.lww.com/psychopharmaco…

What is olfactory reference disorder, and how should it be treated? In our latest Ask the Experts, Dr. Katharine Phillips of Weill Cornell Medicine discusses this underrecognized condition, defined by the persistent false belief of emitting a foul body odor. 🔗 journals.lww.com/psychopharmaco…

A 2025 Executive Order calls SSRIs a “threat” to youth. Our latest editorial and podcast revisit the evidence: #SSRIs remain safe, effective, and essential for many youth with anxiety, depression, and OCD. 🎧Podcast: jcpjournal.libsyn.com/fact-versus-fe… 📰Editorial: journals.lww.com/psychopharmaco…

Our November/December 2025 issue (Volume 45, issue 6) is now available online: journals.lww.com/psychopharmaco… Brief synopsis of the new issue from the Journal of Clinical Psychopharmacology Editor-in-Chief is below.

A new review article in the Journal of Clinical Psychopharmacology challenges key STAR*D findings: Common depression treatment steps may not outperform placebo in blinded RCTs. 🔗 journals.lww.com/psychopharmaco… #psychopharmacology #depression #TRD #antidepressants #STARD #RCT

How should we balance evidence-based medicine with clinical experience in treating depression? Our latest guest editorial challenges Kennedy et al.’s critique of the STAR*D trial, arguing that standard antidepressant RCTs miss real-world complexity. 🔗 journals.lww.com/psychopharmaco…

New Podcast: Anticholinergic Side Effects in Psych Meds Journal of Clinical Psychopharmacology Come learn: 1. Why anticholinergic burden matters 2. Our equivalency scale vs. others 3. Sedation ≠ anticholinergic 4. Antihistamine ≠ anticholinergic 5. Surprising findings + practical tips Thank you JCP for

In a new JCP article and podcast episode, Drs. Nicolas Badre and Eric Geier present a practical #anticholinergic equivalence table to help clinicians assess and minimize psychotropic anticholinergic burden. 🎧 Podcast: podcasts.apple.com/us/podcast/ant… 📰 Article: journals.lww.com/psychopharmaco…

We honor the life and legacy of Dr. Max Fink (1923–2025), a visionary in ECT, catatonia, and clinical psychopharmacology, and a longtime supporter of our journal. His legacy of scholarship and mentorship continues to inspire. 🕯️journals.lww.com/psychopharmaco…

Ketogenic diets are gaining attention as a potential adjunctive treatment for bipolar disorder, but how do they interact with modern psychotropic regimens? Mayo Clinic experts discuss this topic in our new podcast episode. 🎧 podcasts.apple.com/us/podcast/die… 📰 journals.lww.com/psychopharmaco…

Journal of Clinical Psychopharmacology is still accepting applications for its inaugural Editorial Fellowship Program. This two-year, paid fellowship offers hands-on experience in academic publishing and psychiatric research. Learn more below and apply today!

A new analysis of over 17,000 clozapine-related fatalities shows that young and middle-aged females face a notably higher risk of fatal pulmonary embolism, while pneumonia remains the leading fatal outcome in older adults. Read more in our current issue: journals.lww.com/psychopharmaco…

Effects of Coenzyme Q10 Supplementation on Depressive... : Journal of Clinical Psychopharmacology journals.lww.com/psychopharmaco… Journal of Clinical Psychopharmacology

A new study published in JCP finds that prescription #stimulants, particularly #dextroamphetamine and #methylphenidate, are associated with higher rates of sudden death and all-cause #mortality. The risk of mortality appears to increase with age. 🔗 journals.lww.com/psychopharmaco…